Benzimidazoledihydrothiadiazinone derivatives as fructose1,6-bisphosphatase inhibitors, and pharmaceutical compositions comprising same

Details for Australian Patent Application No. 2008323361 (hide)

Owner Merck Patent GmbH

Inventors Arbellot De Vacqueur, Annick; Gleitz, Johannes; Audet, Annick; Botton, Gerard; Leriche, Caroline

Agent Davies Collison Cave

Pub. Number AU-A-2008323361

PCT Pub. Number WO2009/062576

Priority 07291349.4 12.11.07 EP

Filing date 13 October 2008

Wipo publication date 22 May 2009

International Classifications

C07D 417/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

A61K 31/54 (2006.01) - having six-membered rings with at least one nitrogen and at least one sulfur as the ring hetero atoms, e.g. sulthiame

C07D 417/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

1 July 2010 PCT application entered the National Phase

  PCT publication WO2009/062576 Priority application(s): WO2009/062576

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008323375-Method for end-titre determination and the evaluation thereof by means of an indirect immunofluorescence assay

2008323350-Submarine antenna